Product Program year 2020 Source: CMS Open Payments

Olympus Endoscopic Ultrasound Scopes

Device GI & Respiratory Products

Open in the dashboard

General payments

$417,617

102 payments

Research payments

$1,551,894

2 payments

Through program year 2020, $417,617 in general payments and $1,551,894 in research payments were reported against Olympus Endoscopic Ultrasound Scopes (GI & Respiratory Products).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $123,803 17
2020 Research $15,000 1
2019 General $293,815 85
2019 Research $1,536,894 1

Breakdown

Who paid General payments · program years 2019–2020
  1. Olympus Corporation of the Americas $264,805 36 payments
  2. Olympus America Inc. $145,662 60 payments
  3. Olympus Latin America, Inc. $6,070 4 payments
  4. Olympus Corporation $1,081 2 payments
Top recipients General payments · program year 2020
  1. Cedars-Sinai Medical Center Teaching hospital · CA $78,800 64% · 1 payment
  2. The Queens Medical Center Teaching hospital · HI $13,146 11% · 1 payment
  3. Mount Sinai Health System-Beth Israe Teaching hospital · NY $12,822 10% · 1 payment
  4. Kenneth Chang Gastroenterology · Newport Beach, CA $6,765 5% · 2 payments
  5. Ali Moghani Lankarani Gastroenterology · Jacksonville, FL $4,651 4% · 4 payments

The top 5 of 10 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Gastroenterology Internal Medicine $14,555 87% · 5 practitioners
  2. Pulmonary Disease Internal Medicine $2,200 13% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. California $87,845 71% · 3 recipients
  2. Hawaii $13,146 11% · 1 recipient
  3. New York $12,825 10% · 2 recipients
  4. Florida $5,727 5% · 2 recipients
  5. North Carolina $2,200 2% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

102 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record